Press "Enter" to skip to content

New patent for Pfizer drug TOVIAZ

0
Copyright © DrugPatentWatch. Originally published at New patent for Pfizer drug TOVIAZ

Annual Drug Patent Expirations for TOVIAZ
Annual Drug Patent Expirations for TOVIAZ

Toviaz is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for TOVIAZ.

This drug has sixty-nine patent family members in twenty-nine countries.

The generic ingredient in TOVIAZ is fesoterodine fumarate. Two suppliers are listed for this compound. Additional details are available on the fesoterodine fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Pfizer drug TOVIAZ
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions